Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:

Content type

Project (92)
Result in Brief (18)
Report Summary (57)


Argentina (1)
Australia (1)
Austria (10)
Belgium (14)
Chile (1)
Croatia (1)
Czech Republic (3)
Denmark (12)
Estonia (5)
Finland (11)
France (22)
Germany (34)
Greece (4)
Iceland (2)
Ireland (6)
Israel (6)
Italy (20)
Latvia (2)
Luxembourg (1)
Malta (2)
Netherlands (26)
New Caledonia (1)
New Zealand (1)
Norway (7)
Poland (7)
Portugal (11)
Romania (2)
Russia (1)
Serbia (1)
Slovakia (1)
Slovenia (5)
Spain (38)
Sweden (15)
Switzerland (11)
Turkey (2)
United Kingdom (29)
United States (2)

Advanced search

Search projects and results

Results 1 - 10 of 167
12 3 4 5 6 7 8 9 10 > >| 
Periodic Reporting for period 1 - METAFLUIDICS (Advanced toolbox for rapid and cost-effective functional metagenomic screening - microbiology meets microfluidics.)
Enzyme discovery is the first step towards a more sustainable and greener bioeconomy, in which traditional energy intensive and waste generating processes are replaced by milder, enzyme-catalyzed alternatives or even completely redesigned versions. The natural diversity...
Programme: H2020-EU.2.1.4.
Record Number: 223959
Last updated on: 2018-04-10
Periodic Reporting for period 1 - EmPowerPutida (Exploiting native endowments by re-factoring, re-programming and implementing novel control loops in Pseudomonas putida for bespoke biocatalysis)
Synthetic Biology (SynBio) is bound to be transformative in Industrial and Environmental Biotechnology. The powerful methodologies for high-throughput genome engineering, model-driven design and circuit construction, along with new concepts for bioprocess engineering enable...
Programme: H2020-EU.2.1.4.
Record Number: 198419
Last updated on: 2017-05-19
Periodic Reporting for period 1 - DiViNe (Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes)
In the vaccine industry, downstream processing is of extreme importance. Prophylactic vaccines aim at protecting healthy people, so any contaminant has to be removed with the most drastic measures. Such « negative » approach comes at the expense of the recovery of product:...
Programme: H2020-EU.2.1.4.
Record Number: 194893
Last updated on: 2017-02-16
Periodic Reporting for period 1 - RIGVIR (Feasibility study for registration of medicine RIGVIR with the European Medicine Agency)
The Project and accomplished Feasibility study was aimed to ascertain framework for the registration process for medicine RIGVIR® in European Medicine Agency (further in text EMA) and development of Briefing document that fulfils EMA requirements. The special approach was...
Programme: H2020-EU.2.1.4.
Record Number: 198670
Last updated on: 2017-05-23
Periodic Reporting for period 1 - USONIPRO (Ultrasonic technology for bioprocess enhancement)
The aim of the USONIPRO project is to develop and implement a technology, that uses sound wave propagation in order to increase the efficiency of the protein production. Companies that produce proteins in microbiological expression systems are looking for a solution that will...
Programme: H2020-EU.2.1.4.
Record Number: 194888
Last updated on: 2017-02-16
Sulphites are food additives with antioxidant and preservative properties. However, they are recorded as allergens by the main international regulatory bodies on food safety because of their adverse health effects. Hence, sulphites maximum concentration in foodstuff is...
Programme: H2020-EU.2.1.4.
Record Number: 194834
Last updated on: 2017-02-15
Periodic Reporting for period 1 - PEPTO1 (Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy)
Peptomyc S.L. is a spin-off company created at the Vall d’Hebron Institute of Oncology (VHIO) to develop a new, first-in-class, cancer therapy based on the use of innovative anti-Myc peptides. Myc is an oncogene deregulated in the majority of human cancers, making...
Programme: H2020-EU.2.1.4.
Record Number: 194844
Last updated on: 2017-02-15
Periodic Reporting for period 1 - JEM Phase 1 (JEM: The world safest subcutaneous, enclosed, biocompatible implantable device, attached directly to a AV fistula or graft or vein, for chronic disease patients in need of repetitive vascular access)
➢ Millions of chronic disease patients worldwide depend on treatment that requires safe, repetitive access to the vascular system. The major markets are dialysis and oncology patients in need of chemotherapy. Other chronic disease patients, who require regular medications or...
Programme: H2020-EU.2.1.4.
Record Number: 198149
Last updated on: 2017-05-17
Periodic Reporting for period 3 - BIOCURE (Novel Biomaterial for Improved and Cost-efficient Wound Healing)
Wound treatment is a major healthcare cost for all developed countries. In the UK for example, it is estimated that up to 4% of all health care costs are due to wounds . The global market for advanced wound care products was projected to be $ 3 billion in 2012, with an annual...
Programme: H2020-EU.2.1.4.
Record Number: 193062
Last updated on: 2016-12-16
Periodic Reporting for period 1 - nextBioPharmDSP (Next-generation biopharmaceutical downstream process)
The scope of the project is the optimization of downstream processing (DSP) for the production of Biopharmaceuticals. Biopharmaceuticals have been successfully used as efficient therapeutic drugs for many pathophysiological conditions since the first recombinant product...
Programme: H2020-EU.2.1.4.
Record Number: 193053
Last updated on: 2016-12-16
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-04-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top